Charles River Laboratories reinforced its commitment to strengthening the Asia Pacific biomanufacturing ecosystem by sig...
As global demand for biologics, advanced therapies, and complex biopharmaceuticals continues to expand, the conversation...
US-based BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organization (CRDMO), has establi...
Offering scalable quality grades from Research to GMP, PlasmidFactory supports advanced gene-based innovations worldwide...
China-based WuXi XDC Cayman Inc. (WuXi XDC), a leading global CRDMO (Contract Research, Development, and Manufacturing O...
Taiwan-headquartered Bora Pharmaceuticals, a global leader in pharmaceutical manufacturing, and British pharma firm...
US-based Catalent and South Korea-based S.Biomedics have announced a strategic partnership to support the development an...
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Or...
Fujifilm Biotechnologies, a world leading contract development and manufacturing organisation (CDMO) for biologics, vacc...
Vetter, one of the world's leading pharmaceutical service providers for the production of injectable drugs, has confirme...
WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio I...
US-based Rakuten Medical, Inc. and South Korea's Lotte Biologics have signed a biopharmaceutical contract manufacturing ...
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...
How would KBI Biopharma highlight its achievements in 2025? Which key projects strengthened the company’s global C...
Fujifilm Corporation has announced the completion of one of Japan’s largest bio CDMO facilities (the new plan...
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and...
South Korea-based Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has announced...
What were the key highlights at Sygnature Discovery in 2025? Please elaborate upon the company's plans for 2026. Despit...
With the CDMO segment seeing rapid growth, how would you describe the changing profile of your clients, and how is Teiji...
Australia’s first and only clinical and commercial-scale viral vector Contract Development and Manufacturing Organ...
South Korea-based SK pharmteco and LOTTE BIOLOGICS have signed a Letter of Intent (LOI) for a strategic collaboration to...
NEOM, the sustainable region taking shape in northwest Saudi Arabia, has signed a strategic memorandum of understanding ...
South Korea-based Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has unveiled ...
Germany-based Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) ...
South Korea-based Celltrion has signed an agreement with Eli Lilly to acquire a biopharmaceutical drug substance (DS) ma...
